Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials.

Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials. JAMA Neurol. 2019 12 01; 76(12):1466-1473.

View in: PubMed

subject areas

Aspirin
Humans
Ischemic Attack, Transient
Multicenter Studies as Topic
Platelet Aggregation Inhibitors
Randomized Controlled Trials as Topic
Risk Factors
Treatment Outcome

authors with profiles

Jordan J. Elm